Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_provenance.
- NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_assertion description "[The aim of this study was to evaluate whether the neoadjuvant use of the dexamethasone (DEX) plus octreotide (OCT) regimen can improve the direct anticancer effects of docetaxel (DOC) in the TRAMP-C1 prostate cancer model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_provenance.
- NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_assertion evidence source_evidence_literature NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_provenance.
- NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_assertion SIO_000772 22210719 NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_provenance.
- NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_assertion wasDerivedFrom befree-2016 NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_provenance.
- NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_assertion wasGeneratedBy ECO_0000203 NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_provenance.
- befree-2016 importedOn "2016-02-19" NP950289.RALBc0w39XyceoRFW4H2Tp5BHB88oX8__mVWL0sbe4IQ0130_provenance.